![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/en/news-release/2024/07/09/2910231/0/en/Prelude-Therapeutics-Announces-Clinical-Collaboration-with-Merck-to-Evaluate-PRT3789-in-Combination-with-KEYTRUDA-pembrolizumab-in-Patients-with-SMARCA4-Mutated-Cancers.html
https://www.globenewswire.com/news-release/2024/06/03/2892121/0/en/Prelude-Therapeutics-to-Participate-in-Upcoming-Healthcare-Conferences.html
https://www.globenewswire.com/news-release/2024/05/09/2878622/0/en/Prelude-Therapeutics-to-Participate-in-Citizens-JMP-Life-Sciences-Conference.html
https://www.globenewswire.com/news-release/2024/05/07/2876568/0/en/Prelude-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/09/2860397/0/en/Prelude-Highlights-Continued-Strength-of-Discovery-Engine-at-2024-AACR-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/03/05/2840964/0/en/Prelude-Announces-Acceptance-of-Multiple-Preclinical-Abstracts-at-the-2024-AACR-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/29/2838405/0/en/Prelude-Therapeutics-to-Participate-in-Barclays-Global-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/02/15/2830378/0/en/Prelude-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Outlines-Key-Objectives-for-2024.html
https://www.globenewswire.com//news-release/2023/12/11/2793967/0/en/Prelude-Therapeutics-Announces-25-Million-Private-Placement.html
https://www.globenewswire.com//news-release/2023/11/01/2771735/0/en/Prelude-Announces-Strategic-Pipeline-Progress-and-Updates-including-its-Partnership-with-AbCellera-and-Reports-Third-Quarter-Financial-Results.html